STOCK TITAN

Valion Bio executive settles 4 stock units for shares

The RSU and tax-withholding counts reflect a 1-for-25 reverse stock split on August 31, 2026.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Valion Bio, Inc. COO & CFO Lisa G. Wolf reported settlement of 4 restricted stock units for 4 common shares on September 18, 2026. Two common shares were forfeited for tax withholdings, using a market price of $2.12 per share. The reported post-transaction position was 19 restricted stock units. The RSU and tax-withholding counts reflect the 1-for-25 reverse stock split on August 31, 2026; no Rule 10b5-1 plan is reported.

Positive

  • None.

Negative

  • None.
Insider Wolf Lisa G
Role COO & CFO
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F3, F4 4 $0.00 $0.00
Exercise Common Stock F1, F3 4 -- --
Tax Withholding Common Stock F2, F4 2 $2.12 $4.24
Holdings After Transaction: Restricted Stock Units — 19 contracts (Direct); Common Stock — 27 shares (Direct)
Footnotes (4)
  1. F1. Each Restricted Stock Unit is convertible into one share of Common Stock.
  2. F2. The Reporting Person forfeited 2 shares of Common Stock upon vesting and settlement of 4 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's Common Stock at the time of forfeiture.
  3. F3. Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the "Vesting Commencement Date"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date.
  4. F4. These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026.
Restricted stock units settled 4 restricted stock units Settlement reported for September 18, 2026
Common shares acquired 4 shares Upon settlement of restricted stock units on September 18, 2026
Common shares forfeited 2 shares For tax withholdings on September 18, 2026
Market price $2.12 per share Price used at forfeiture for tax withholdings
Restricted stock units following transaction 19 restricted stock units Reported post-transaction position
Reverse stock split 1-for-25 Occurred August 31, 2026; RSU and tax-withholding counts reflect the split
Restricted Stock Units financial
"settlement of 4 outstanding Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholdings financial
"to cover tax withholdings"
Vesting Commencement Date financial
"December 18, 2024 (the "Vesting Commencement Date")"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
reverse stock split financial
"underwent a reverse stock split at a ratio of 1-for-25"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What RSU transaction did VBIO's COO and CFO report?

Lisa G. Wolf reported settlement of 4 restricted stock units for 4 common shares on September 18, 2026; 2 common shares were forfeited for tax withholdings at a market price of $2.12 per share. No Rule 10b5-1 plan is reported.

What vesting schedule applies to VBIO's restricted stock units?

Fifty percent of the restricted stock units vested upon the one-year anniversary of December 18, 2024. The balance will vest in eight successive equal quarterly installments measured from that anniversary, so that 100% will have vested on the third anniversary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wolf Lisa G

(Last)(First)(Middle)
1305 E. HOUSTON ST., BLDG 1, STE. 311

(Street)
SAN ANTONIO TEXAS 78205

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Valion Bio, Inc. [ VBIO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
COO & CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/18/2026M4A(1)29(3)D
Common Stock09/18/2026F(2)2D$2.1227(4)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)09/18/2026M4 (3) (3)Common Stock4$019(4)D
Explanation of Responses:
1. Each Restricted Stock Unit is convertible into one share of Common Stock.
2. The Reporting Person forfeited 2 shares of Common Stock upon vesting and settlement of 4 outstanding Restricted Stock Units to cover tax withholdings, using the market price of the Issuer's Common Stock at the time of forfeiture.
3. Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the "Vesting Commencement Date"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date.
4. These numbers have been adjusted to reflect the reverse stock split of the Common Stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026.
/s/ Lisa Wolf09/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading